Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors

被引:0
|
作者
Érica Cristina Moreno Nascimento
João B. L. Martins
机构
[1] Universidade de Brasília,Laboratório de Química Computacional, LQC
[2] Instituto de Química,undefined
来源
关键词
Acetylcholinesterase inhibitors; Alzheimer´s disease; B3LYP; Molecular modeling; PCA;
D O I
暂无
中图分类号
学科分类号
摘要
Hartree-Fock and density functional methods were used to analyze electronic and structural properties of known drugs to evaluate the influence of these data on acetylcholinesterase inhibition. The energies of the frontier orbitals and the distances between the more acidic hydrogen species were investigated to determine their contributions to the activity of a group of acetylcholinesterase inhibitors. Electrostatic potential maps indicated suitable sites for drugs-enzyme interactions. In this study, the structural, electronic and spatial properties of nine drugs with known inhibitory effects on acetylcholinesterase were examined. The data were obtained based on calculations at the B3LYP/6-31 + G(d,p) level. Multivariate principal components analysis was applied to 18 parameters to determine the pharmacophoric profile of acetylcholinesterase inhibitors. Desirable features for acetylcholinesterase inhibitor molecules include aromatic systems or groups that simulate the surface electrostatic potential of aromatic systems and the presence of a sufficient number of hydrogen acceptors and few hydrogen donors. PCA showed that electronic properties, including the HOMO-1 orbital energy, logP and aromatic system quantity, as well as structural data, such as volume, size and H-H distance, are the most significant properties.
引用
收藏
页码:1371 / 1379
页数:8
相关论文
共 50 条
  • [1] Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors
    Moreno Nascimento, Erica Cristina
    Martins, Joao B. L.
    JOURNAL OF MOLECULAR MODELING, 2011, 17 (06) : 1371 - 1379
  • [2] Dynamics of human acetylcholinesterase bound to non-covalent and covalent inhibitors shedding light on changes to the water network structure
    Peters, Judith
    Martinez, Nicolas
    Trovaslet, Marie
    Scannapieco, Kevin
    Koza, Michael Marek
    Masson, Patrick
    Nachon, Florian
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2016, 18 (18) : 12992 - 13001
  • [3] Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors
    Zain, Rula
    Vihinen, Mauno
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] Non-Covalent Proteasome Inhibitors
    Kaffy, Julia
    Bernadat, Guillaume
    Ongeri, Sandrine
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (22) : 4115 - 4130
  • [5] Crystal and electronic structure of thiazolium pentaiodide: an experimental and theoretical study of covalent and non-covalent bonds
    Tatiana A. Shestimerova
    Ivan A. Andreev
    Nina K. Ratmanova
    Igor V. Trushkov
    Alexey N. Kuznetsov
    Andrei V. Shevelkov
    Structural Chemistry, 2023, 34 : 1557 - 1564
  • [6] Crystal and electronic structure of thiazolium pentaiodide: an experimental and theoretical study of covalent and non-covalent bonds
    Shestimerova, Tatiana A.
    Andreev, Ivan A.
    Ratmanova, Nina K.
    Trushkov, Igor V.
    Kuznetsov, Alexey N.
    Shevelkov, Andrei V.
    STRUCTURAL CHEMISTRY, 2023, 34 (04) : 1557 - 1564
  • [7] Structurally-Diverse Non-Covalent Allosteric KRAS Inhibitors Structurally Diverse Non-Covalent Allosteric KRAS Inhibitors
    Pagba, Cynthia
    Gupta, Amit K.
    McCarthy, Michael
    Zhou, Yong
    Gorfe, Alemayehu A.
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 324A - 324A
  • [8] Non-covalent acetylcholinesterase inhibitors: In vitro screening and molecular modeling for novel selective insecticides
    Hepnarova, Vendula
    Hrabinova, Martina
    Muckova, Lubica
    Kucera, Tomas
    Schmidt, Monika
    Dolezal, Rafael
    Gorecki, Lukas
    Hrabcova, Veronika
    Korabecny, Jan
    Mezeiova, Eva
    Jun, Daniel
    Pejchal, Jaroslav
    TOXICOLOGY IN VITRO, 2022, 85
  • [9] Non-covalent associative structure of coal
    水恒福
    JournalofCoalScience&Engineering(China), 2004, (01) : 60 - 64
  • [10] Development of non-covalent reversible proteasome inhibitors
    Kazi, Aslamuzzaman
    Ozcan, Sevil
    Lawrence, Harshani
    Sebti, Said M.
    CANCER RESEARCH, 2012, 72